Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications
Response Rate, Event-Free Survival, and Overall Survival in Newly Diagnosed Acute Myeloid Leukemia: US Food and Drug Administration Trial-Level and Patient-Level Analyses.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 10, 2021
ASH Research Collaborative: a real-world data infrastructure to support real-world evidence development and learning healthcare systems in hematology.
Journal: Blood advances
Published: August 09, 2021
FDA Approval Summary: Gilteritinib for Relapsed or Refractory Acute Myeloid Leukemia with a FLT3 Mutation.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 03, 2020
Differentiation Syndrome with Ivosidenib and Enasidenib Treatment in Patients with Relapsed or Refractory IDH-Mutated AML: A U.S. Food and Drug Administration Systematic Analysis.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 03, 2020
Defining the path ahead for NOAC use in the pediatric population: A Cardiac Safety Research Consortium Think Tank.
Journal: American heart journal
Published: February 18, 2020
FDA review summary of patient-reported outcome results for ibrutinib in the treatment of chronic graft versus host disease.
Journal: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
Published: February 12, 2020
FDA approval summary: Dalteparin for the treatment of symptomatic venous thromboembolism in pediatric patients.
Journal: Pediatric blood & cancer
Published: January 26, 2020
Systematic Review of PD-1/PD-L1 Inhibitors in Oncology: From Personalized Medicine to Public Health.
Systematic Review of PD-1/PD-L1 Inhibitors in Oncology: From Personalized Medicine to Public Health.
Journal: The oncologist
Published: November 07, 2019
Older adults in hematologic malignancy trials: Representation, barriers to participation and strategies for addressing underrepresentation.
Journal: Blood reviews
Published: September 16, 2019
End points for sickle cell disease clinical trials: patient-reported outcomes, pain, and the brain.
Journal: Blood advances
Published: August 23, 2019
Last Updated: 09/26/2026